
Opinion|Videos|September 20, 2024
Current Advancements in Biomarker Research
The panel explores promising biomarker research that has the potential to significantly impact patient care in prostate cancer.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- What current advancements in biomarker research are you most excited about? (Brian Richardson, MD)
- Lysine-specific demethylase-1
- Appl1, Sortilin, and Syndecan-1
- Please highlight any others.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves first-line Zenflow system for the treatment of BPH
3
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5























